Cargando…
Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
Malignant pleural mesothelioma (MPM) is a rare neoplasm, generally caused by asbestos exposure. This case details how a patient treated with nintedanib during the LUME‐Meso study was rechallenged with nintedanib. The findings highlight the benefit of nintedanib rechallenge and the potential use of c...
Autores principales: | Grosso, Federica, Roveta, Annalisa, Gallizzi, Giulia, Belletti, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186873/ https://www.ncbi.nlm.nih.gov/pubmed/30349716 http://dx.doi.org/10.1002/ccr3.1775 |
Ejemplares similares
-
Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab
por: Minchom, Anna, et al.
Publicado: (2020) -
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021) -
Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite Chemotherapy
por: Saint-Pierre, Mathieu D., et al.
Publicado: (2015) -
Recurrent hydropneumothorax: An unusual presentation for malignant pleural mesothelioma
por: DeLapp, David, et al.
Publicado: (2016) -
Near-Infrared Intraoperative Imaging Can Successfully Identify Malignant Pleural Mesothelioma After Neoadjuvant Chemotherapy
por: Predina, Jarrod D., et al.
Publicado: (2017)